Latest Breaking News On - National medical products administration on - Page 1 : comparemela.com

AI Watch: Global regulatory tracker - China | White & Case LLP

AI Watch: Global regulatory tracker - China | White & Case LLP
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

Republic of chinaTaiwan generalCity ofUnited kingdomInsurance regulatory commissionNational radioNational developmentNational medical products administration onMinistry of agricultureTelevision administrationRural affairsChinese academy of sciencesAdministration for market regulationTechnology commission of the central militaryReform commissionChinese academy of social sciences

The U S FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer

/PRNewswire/ Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as "Leads Biolabs" or "Company") today announces that the phase I/II clinical trial.

United statesCharles caiNational medical products administration onBiolabs or companyBiolabs co ltdDrug administrationSun yat sen university cancer centerChief medical officerLeads biolabsNational medical products administrationSun yat sen university cancer

China s first home-grown mRNA COVID vaccine rolled out in Hebei

China s first home-grown mRNA COVID vaccine rolled out in Hebei
globalsecurity.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalsecurity.org Daily Mail and Mail on Sunday newspapers.

Zeng guangWang guangfaSina weiboZhuang shiliheFosun pharmaNational medical products administration onUniversity first hospitalChinese centerCentral leading group for novel coronavirus preventionNational administration of disease preventionGlobal times publishedNorth chinaHebei provinceCentral leading groupNovel coronavirus preventionSino cell tech

China s first home-grown mRNA COVID vaccine rolled out in Hebei

China s first domestically developed mRNA vaccine for COVID-19 was initially put into use in Shijiazhuang, North China s Hebei Province on Sunday.

Zeng guangZhuang shiliheWang guangfaSina weiboFosun pharmaNational administration of disease preventionUniversity first hospitalNational medical products administration onChinese centerCentral leading group for novel coronavirus preventionNorth chinaHebei provinceCentral leading groupNovel coronavirus preventionSino cell techNational medical products administration

Sinopharm wins approval for inhaled Omicron antibody trials

Chinese drugmaker Sinopharm said on Monday it has obtained approval to conduct clinical trials of an inhaled monoclonal antibody against the novel coronavirus, a potentially significant weapon against the dominant Omicron variant.

National medical products administration onChina national biotech groupBattle against novelNational biotech groupNational medical products administration